Quantcast

Latest tumor Stories

2014-07-25 23:03:27

Brian Olson Discusses Diagnosis, Importance of Patient Resources and Support Chicago, IL (PRWEB) July 25, 2014 There are 700,000 people in the U.S. living with a brain tumor, and 500 diagnosed each day. Though when someone hears the words, “you have a brain tumor,” they often feel alone, confused and are unsure of the next step and where to turn. The American Brain Tumor Association (ABTA) is helping people figure out that next step by providing and pursuing the answers patients so...

2014-07-25 23:03:18

Harvard Neuro-Oncologist presents latest brain tumor research and treatment options at American Brain Tumor Association’s annual conference. Chicago, IL (PRWEB) July 25, 2014 Progress in understanding the molecular genetics of brain tumors has ushered in a new era of promising brain tumor treatments, according to Patrick Wen, MD, professor of neurology, Harvard Medical School, director of the Center for Neuro-Oncology, Dana-Farber Cancer Institute. At the American Brain Tumor...

2014-07-23 23:18:30

Transparency Market Research published a new report "Circulating Tumor Cells (CTCs) Prognostic Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report store. Browse the full report: http://www.transparencymarketresearch.com/ctcs-prognostic-technologies-market.html Albany, New York (PRWEB) July 22, 2014 According to a new market report published by Transparency Market Research “Circulating Circulating Tumor Cells (CTCs)...

2014-07-22 08:32:26

Pioneer in uniting imaging technology with radiotherapy to explore potential of MRI to refine tumor targeting MANCHESTER, England, July 22, 2014 /PRNewswire/ -- Elekta (NSE:EKTAb) and Royal Philips (NYSE:PHG, AEX:PHIA) announced today that The Christie NHS Foundation Trust (Manchester, UK), a specialist cancer center, will join a consortium whose mission is to develop the clinical value of an integrated magnetic resonance imaging (MRI) guided radiation therapy system. Such a system...

2014-07-15 23:00:16

Researchers at the Western Connecticut Health Network Biomedical Research Institute use a multidisciplinary integrated approach to discover possible predictive biomarkers of tumor behavior for people with colon cancer. Danbury, Connecticut (PRWEB) July 16, 2014 The goal of finding effective treatments for people with colorectal cancer based on their unique molecular characteristics is still elusive. Researchers from the Western Connecticut Health Network Biomedical Research Institute have...

Researchers Discover New Route For Ovarian Cancer Spread
2014-07-15 03:14:42

University of Texas M. D. Anderson Cancer Center HER3-positive circulating tumor cells home in on omentum; new target to thwart metastasis Circulating tumor cells spread ovarian cancer through the bloodstream, homing in on a sheath of abdominal fatty tissue where it can grow and metastasize to other organs, scientists at The University of Texas MD Anderson Cancer Center report in Cancer Cell. "This completely new way of thinking about ovarian cancer metastasis provides new potential...

2014-07-15 08:28:28

Eighty Percent of Patients Treated with G-202 had No Tumor Growth at Two Months SAN ANTONIO, July 15, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, releases the APPLE 2014 presentation. Devalingam Mahalingam, MD, PhD, Principal Investigator of the G-202 Phase II trial in hepatocellular carcinoma (HCC) patients, presented the HCC clinical trial update for G-202 at the 5(th) Asia-Pacific Primary Liver...

2014-07-11 23:09:19

Capital Institute for Neurosciences Begins Clinical Trial Delivering Chemotherapy Directly to Brain Tumors Starting with Incision in Leg Hopewell, NJ (PRWEB) July 11, 2014 The Capital Institute for Neurosciences at Capital Health today announced it has performed the first procedure in a clinical trial that delivers chemotherapy to brain tumors through a catheter inserted in the leg. During the procedure, done at Capital Health Medical Center – Hopewell, Dr. Erol Veznedaroglu, an...

2014-07-11 10:56:11

Massachusetts General Hospital Circulating tumor cells captured with a microchip-based device developed at the Massachusetts General Hospital (MGH) Center for Engineering in Medicine and the MGH Cancer Center can be cultured to establish cell lines for genetic analysis and drug testing. In the July 11 issue of Science, an MGH research team reports that the cultured cells accurately reflect a tumor's genetic mutation over time and changing susceptibility to therapeutic drugs. "We now...

2014-07-10 12:22:20

Fox Chase Cancer Center Study Finds that Some Women Do Better than Current Staging Guidelines Suggest New findings from Fox Chase Cancer Center paint a relatively optimistic picture of women’s chances of surviving a subset of breast cancers that have spread to the chest wall or skin, but not beyond. Tumors that grow into the skin, regardless of size and whether they have involved lymph nodes, are automatically classified as stage III – and called “locally advanced” tumors,...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related